En Es
Categorías

PERKIN ELMER CORPORATION

PerkinElmer provides detection technologies to detect and identify diseases, imaging technologies to help visualize simple to complex diseases, and informatics and software platforms to provide visualization, efficient workflow, data management and analytics. The company’s detection and imaging technologies, laborator ...
Productos Covid-19NoticiasResumen
Close

Covid-19 PERKIN ELMER CORPORATION

Laboratorio clínico

COVID-19 Antigen Test
PerkinElmer COVID-19 Antigen Test

The PerkinElmer COVID-19 Antigen Test is a CE marked in vitro diagnostic device for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens. The lateral flow immunoassay test can be used to screen or aid in the diagnosis of COVID-19 in asymptomatic or symptomatic individuals. A positive or negative result can be obtained as early as 15 minutes to facilitate immediate isolation or treatment decisions. The test is ideally suited for point-of-care (POC) clinical and non-clinical settings such as healthcare centers, travel hubs, businesses and educational institutions.
Mas detalles

SARS-CoV-2 Variant Test Kit
NEXTFLEX Variant-Seq SARS-CoV-2 Kit

The NEXTFLEX Variant-Seq SARS-CoV-2 Kit is optimized to quickly, easily, and affordably identify all mutations in a SARS-CoV-2 sample by utilizing an amplicon-based target enrichment workflow which offers many advantages over hybridization capture-based protocols, most notably speed, scalability, and cost. The kit simplifies the identification of existing and new variants of the SARS-CoV-2 virus by greatly reducing the sample preparation needed prior to sequencing and is powered by COSMOSID software, converting sequencing data into a concise sample report within minutes.
Mas detalles

SARS-CoV-2, Flu A/B, RSV Assay
PKamp Respiratory SARS-CoV-2 RT-PCR Panel Assa

The PKamp Respiratory SARS-CoV-2 RT-PCR Panel Assay is a real-time RT-PCR multiplexed test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), or simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B, or qualitative detection of SARS-CoV-2 only. The CE-IVD marked assay targets two specific genomic regions of SARS-CoV-2: the nucleocapsid (N) gene and ORF1ab.
Mas detalles

Coronavirus Test
PerkinElmer® New Coronavirus Nucleic Acid Detection Kit

The PerkinElmer® New Coronavirus Nucleic Acid Detection Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in human oropharyngeal, nasopharyngeal, and anterior nasal swab samples. It has a limit of detection 20 copies/mL for the SARS-CoV-2 ORF1ab and N genes, and does not show cross reactivity with common respiratory tract pathogens and blood stream pathogens.
Mas detalles

SARS-CoV-2 Assay
PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay

The PerkinElmer® SARS-CoV-2 Real-time RT-PCR assay is CE-IVD marked and intended for in vitro diagnostic use in Europe. The assay provides reliable and high-quality results for the clinical detection of COVID-19 in human oropharyngeal swab, nasopharyngeal swab, bronchoalveolar lavage (BAL), sputum, plasma or serum samples. It has a limit of detection 20 copies/mL for the SARS-CoV-2 ORF1ab and N genes using a 400 µL sample, and does not show cross reactivity with common respiratory tract pathogens and blood stream pathogens.
Mas detalles

Anti-SARS-CoV-2 IgG Kit
PerkinElmer® GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit

The PerkinElmer® GSP®/DELFIA® Anti-SARS-CoV-2 IgG kit is intended for the qualitative detection of human antibodies of the immunoglobulin class IgG against SARS-CoV-2 in human blood specimens dried on filter paper and in human serum as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. The kit has been designed to run dried blood samples on the fully automated and high throughput screening GSP® instrument, as well as serum/plasma on a manual time-resolved fluorescence reader, e.g. VICTOR2™ D instrument.
Mas detalles

Anti-SARS-CoV-2 IgG Kit
SuperFlex™ Anti-SARS-CoV-2 IgG Kit

The SuperFlex™ Anti-SARS-CoV-2 kit utilizes direct chemiluminescence technology to detect anti-SARS-CoV-2 IgG antibodies in human serum, plasma (EDTA, sodium citrate), or venous whole blood samples with a sandwich immunoassay. Samples are run on the SuperFlex™ Chemiluminescent Immunoassay system, allowing hands-free analysis of up to 48 samples per hour to quickly identify recent or prior infections. This kit is CE-IVD marked and intended for in vitro diagnostic use in Europe.
Mas detalles

SARS-CoV-2 Nucleic Acid Detection Kit
PerkinElmer® SARS-CoV-2 Nucleic Acid Detection Kit

The PerkinElmer® SARS-CoV-2 Nucleic Acid Detection Kit (RUO) PCR assay can be used to identify SARS-CoV-2 ORF1ab and N genes in 400 µL of in human oropharyngeal, nasopharyngeal, and anterior nasal swab samples. It uses fluorescent-labeled probes specific to the 2019 coronavirus (SARS-CoV-2) open reading frame 1ab (ORF1ab) and nucleocapsid protein (N) genes for streamlining laboratory-developed SARS-CoV-2 testing. It has a limit of detection 20 copies/mL for the SARS-CoV-2 ORF1ab and N genes, and does not show cross reactivity with common respiratory tract pathogens and blood stream pathogens.
Mas detalles

SARS-CoV-2 (COVID-19) Test
EURORealTime SARS-CoV-2 RT-PCR

The EURORealTime SARS-CoV-2 RT-PCR is a CE-marked PCR test for the specific detection of SARS-CoV-2 and direct detection of COVID-19 pathogens by means of reverse transcription and real-time PCR in one step. It offers high sensitivity due to simultaneous detection of two SARS-CoV-2 target sequences and only one reaction per sample.
Mas detalles

Anti-SARS-CoV-2 ELISA (IgG) Test
Anti-SARS-CoV-2 ELISA (IgG) authorized under FDA EUA

The Anti-SARS-CoV-2 ELISA (IgG) test authorized under FDA EUA is intended for the specific detection of IgG antibodies against SARS-CoV-2 using the S1 domain of the spike protein including the immunologically relevant receptor binding domain (RBD). It makes fully automated processing and evaluation possible, and has also been validated for the use of dried capillary blood (dried blood spots – DBS) as alternative sample material, with fully automated DBS processing possible.
Mas detalles

ESTACIÓN DE TRABAJO DE PCR
JANUS® G3 PCR Workstation

La estación de trabajo PCR JANUS® G3 permite preparar muestras de PCR en tiempo real de manera rastreable y reproducible para detección de SARS-CoV-2 de alto rendimiento. La estación de trabajo automatizada ofrece una preparación de muestras de PCR manos libres.
Mas detalles

Nucleic Acid Extractor
chemagic™ 360 Instrument

The chemagic™ 360 Instrument is a nucleic acid extractor for medium to high throughput laboratories that features a revolutionary compact benchtop design and offers a flexible solution for different sample processing and throughput needs. Based on PerkinElmer’s patented chemagen magnetic bead technology, the chemagic™ 360 instrument represents the ideal solution for nucleic acid isolation in a huge variety of research market segments, including but not limited to Biobanking/Human Genetics, HLA Typing, Virus and Bacteria Detection.
Mas detalles

KITS DE ADN/ARN VIRAL
Viral DNA/RNA chemagic™ Kits

El kit Viral DNA/RNA chemagic ™ Viral DNA / RNA 300, de PerkinElmer, ofrece una extracción de ARN rápida y de alta calidad de hisopados nasales, orofaríngeos, nasofaríngeos y anteriores.
Mas detalles
Close

Noticias of PERKIN ELMER CORPORATION

PerkinElmer comprará la compañía de diagnóstico in vitro del Reino Unido Immunodiagnostic Systems

12 Jul 2021
PerkinElmer comprará la compañía de diagnóstico in vitro del Reino Unido Immunodiagnostic Systems
PerkinElmer, Inc. (Waltham, MA; EUA) e Immunodiagnostic Systems Holdings PLC (IDS; Boldon, Tyne and Wear, Reino Unido), llegaron a un acuerdo mediante el cual PerkinElmer adquirirá IDS por aproximadamente 155 millones de dólares.
Más info

PerkinElmer to Acquire UK In-Vitro Diagnostics Company Immunodiagnostic Systems

18 May 2021
PerkinElmer to Acquire UK In-Vitro Diagnostics Company Immunodiagnostic Systems
PerkinElmer, Inc. (Waltham, MA; USA) and Immunodiagnostic Systems Holdings PLC (IDS; Boldon, Tyne and Wear, UK) have reached an agreement whereby PerkinElmer will acquire IDS for approximately USD 155 million.
Más info

PerkinElmer’s EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics

17 Mar 2021
PerkinElmer’s EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics
 EUROIMMUN, a PerkinElmer, Inc. (Waltham, MA; USA) company, has launched the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the Company’s well-established EUROLabOffice 4.0 (ELO 4.0) laboratory management software.
Más info

PerkinElmer to Acquire Oxford Immunotec Global PLC

08 Jan 2021
PerkinElmer to Acquire Oxford Immunotec Global PLC
PerkinElmer, Inc. (Waltham, MA; USA) has reached an agreement to acquire Oxford Immunotec Ltd. (Abingdon, UK) that will allow the company to grow its portfolio of advanced infectious disease testing solutions to include tuberculosis detection.
Más info
Close

Sobre PERKIN ELMER CORPORATION

PerkinElmer provides detection technologies to detect and identify diseases, imaging technologies to help visualize simple to complex diseases, and informatics and software platforms to provide visualization, efficient workflow, data management and analytics. The company’s detection and imaging technologies, laboratory services, and informatics solutions are ideal for scientists, clinicians, and lab professionals.
Facebook Twitter Google+ Linked in
SARS-CoV-2 (COVID-19) Test

SARS-CoV-2 (COVID-19) Test

Modelo: EURORealTime SARS-CoV-2 RT-PCR
Solicite información

Descripción:

The EURORealTime SARS-CoV-2 RT-PCR is a CE-marked PCR test for the specific detection of SARS-CoV-2 and direct detection of COVID-19 pathogens by means of reverse transcription and real-time PCR in one step. It offers high sensitivity due to simultaneous detection of two SARS-CoV-2 target sequences and only one reaction per sample.

Especificaciones:

Especificaciones:

• CE-marked PCR test for specific detection of SARS-CoV-2
• Quick and simple pathogen detection by means of reverse transcription and real-time PCR in one step
• High sensitivity due to simultaneous detection of two SARS-CoV-2 target sequences
• Only one reaction per sample Solicite información

Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
PERKIN ELMER CORPORATION ()
* Mensaje

Derecho de autor © 2000-2021 TradeMed.com. Todos los derechos reservados. | Términos y condiciones